Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis

Saved in:
Bibliographic Details
Main Authors: T. Amaral, E. Chatziioannou, A. Nuebling, T. Sinnberg, H. Niessner, U. Leiter, J. Dwarkasing, T. Arentsen, C. Groß, A. Eggermont, L. Flatz, S. Forchhammer
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EJC Skin Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2772611824001149
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846159034464337920
author T. Amaral
E. Chatziioannou
A. Nuebling
T. Sinnberg
H. Niessner
U. Leiter
J. Dwarkasing
T. Arentsen
C. Groß
A. Eggermont
L. Flatz
S. Forchhammer
author_facet T. Amaral
E. Chatziioannou
A. Nuebling
T. Sinnberg
H. Niessner
U. Leiter
J. Dwarkasing
T. Arentsen
C. Groß
A. Eggermont
L. Flatz
S. Forchhammer
author_sort T. Amaral
collection DOAJ
format Article
id doaj-art-79e6686d96e1436d8cf0c61220a6a7be
institution Kabale University
issn 2772-6118
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series EJC Skin Cancer
spelling doaj-art-79e6686d96e1436d8cf0c61220a6a7be2024-11-24T04:14:54ZengElsevierEJC Skin Cancer2772-61182024-01-012100126Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysisT. Amaral0E. Chatziioannou1A. Nuebling2T. Sinnberg3H. Niessner4U. Leiter5J. Dwarkasing6T. Arentsen7C. Groß8A. Eggermont9L. Flatz10S. Forchhammer11Center for Dermatooncology, Eberhard Karls University of Tuebingen, Tuebingen, Germany; iFIT Cluster of Excellence, Tuebingen, GermanyiFIT Cluster of Excellence, Tuebingen, Germany; Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, GermanyCenter for Dermatooncology, Eberhard Karls University of Tuebingen, Tuebingen, GermanyCenter for Dermatooncology, Eberhard Karls University of Tuebingen, Tuebingen, Germany; Skin Tumor Center Charité, Berlin, GermanyCenter for Dermatooncology, Eberhard Karls University of Tuebingen, Tuebingen, Germany; iFIT Cluster of Excellence, Tuebingen, GermanyCenter for Dermatooncology, Eberhard Karls University of Tuebingen, Tuebingen, GermanySkylineDx BV, Rotterdam, The NetherlandsSkylineDx BV, Rotterdam, The NetherlandsSkylineDx BV, Rotterdam, The NetherlandsUniversity Medical Center Utrecht & Princess Máxima Center, Utrecht, The NetherlandsDepartment of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, GermanyDepartment of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germanyhttp://www.sciencedirect.com/science/article/pii/S2772611824001149
spellingShingle T. Amaral
E. Chatziioannou
A. Nuebling
T. Sinnberg
H. Niessner
U. Leiter
J. Dwarkasing
T. Arentsen
C. Groß
A. Eggermont
L. Flatz
S. Forchhammer
Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
EJC Skin Cancer
title Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
title_full Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
title_fullStr Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
title_full_unstemmed Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
title_short Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
title_sort identification of patients at high risk for relapse by merlin assay cp gep in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy head and neck subgroup analysis
url http://www.sciencedirect.com/science/article/pii/S2772611824001149
work_keys_str_mv AT tamaral identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT echatziioannou identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT anuebling identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT tsinnberg identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT hniessner identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT uleiter identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT jdwarkasing identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT tarentsen identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT cgroß identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT aeggermont identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT lflatz identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis
AT sforchhammer identificationofpatientsathighriskforrelapsebymerlinassaycpgepinanindependentcohortofpatientswithmelanomawhodidnotundergosentinellymphnodebiopsyheadandnecksubgroupanalysis